These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 29750504)

  • 1. C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.
    Tavano R; Gabrielli L; Lubian E; Fedeli C; Visentin S; Polverino De Laureto P; Arrigoni G; Geffner-Smith A; Chen F; Simberg D; Morgese G; Benetti EM; Wu L; Moghimi SM; Mancin F; Papini E
    ACS Nano; 2018 Jun; 12(6):5834-5847. PubMed ID: 29750504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q.
    Ding T; Sun J
    Pharm Res; 2019 Dec; 37(1):10. PubMed ID: 31872347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement opsonization of nanoparticles: Differences between humans and preclinical species.
    Li Y; Wang G; Griffin L; Banda NK; Saba LM; Groman EV; Scheinman R; Moghimi SM; Simberg D
    J Control Release; 2021 Oct; 338():548-556. PubMed ID: 34481928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curvature-dependent effects of nanotopography on classical immune complement activation.
    Westas Janco E; Hulander M; Andersson M
    Acta Biomater; 2018 Jul; 74():112-120. PubMed ID: 29723704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.
    Kang YS; Do Y; Lee HK; Park SH; Cheong C; Lynch RM; Loeffler JM; Steinman RM; Park CG
    Cell; 2006 Apr; 125(1):47-58. PubMed ID: 16615889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continual low-level activation of the classical complement pathway.
    Manderson AP; Pickering MC; Botto M; Walport MJ; Parish CR
    J Exp Med; 2001 Sep; 194(6):747-56. PubMed ID: 11560991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of PEG chain on the complement activation suppression and longevity in vivo prolongation of the PCL biomedical nanoparticles.
    Shan X; Yuan Y; Liu C; Tao X; Sheng Y; Xu F
    Biomed Microdevices; 2009 Dec; 11(6):1187-94. PubMed ID: 19609680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation by IgG containing immune complexes regulates the interaction of C1q with its ligands.
    Hester CG; Frank MM
    Mol Immunol; 2019 Dec; 116():117-130. PubMed ID: 31634815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system.
    Rupprecht TA; Angele B; Klein M; Heesemann J; Pfister HW; Botto M; Koedel U
    J Immunol; 2007 Feb; 178(3):1861-9. PubMed ID: 17237437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway.
    Espericueta V; Manughian-Peter AO; Bally I; Thielens NM; Fraser DA
    Mol Immunol; 2020 Jan; 117():65-72. PubMed ID: 31739194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory roles of C1q.
    Lu J; Wu X; Teh BK
    Immunobiology; 2007; 212(4-5):245-52. PubMed ID: 17544810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A star-shaped poly(2-methyl-2-oxazoline)-based antifouling coating: Application in investigation of the interaction between acetaminophen and bovine serum albumin by frontal analysis capillary electrophoresis.
    Du H; Zhang C; Mao K; Wang Y
    Talanta; 2017 Aug; 170():275-285. PubMed ID: 28501170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
    Clay CD; Soni S; Gunn JS; Schlesinger LS
    J Immunol; 2008 Oct; 181(8):5568-78. PubMed ID: 18832715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D; Brouwer MC; Daha MR; Hack CE
    Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune humoral factors, C1q and factor H, with differential pattern recognition properties, alter macrophage response to carbon nanotubes.
    Pondman KM; Pednekar L; Paudyal B; Tsolaki AG; Kouser L; Khan HA; Shamji MH; Ten Haken B; Stenbeck G; Sim RB; Kishore U
    Nanomedicine; 2015 Nov; 11(8):2109-18. PubMed ID: 26169151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin in the protein corona plays a key role in the stealth effect of nanoparticles against phagocytes.
    Aoyama M; Hata K; Higashisaka K; Nagano K; Yoshioka Y; Tsutsumi Y
    Biochem Biophys Res Commun; 2016 Nov; 480(4):690-695. PubMed ID: 27983983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin binds C1q and activates the classical pathway of complement.
    Peake PW; Shen Y; Walther A; Charlesworth JA
    Biochem Biophys Res Commun; 2008 Mar; 367(3):560-5. PubMed ID: 18179772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover.
    Hamad I; Christy Hunter A; Rutt KJ; Liu Z; Dai H; Moein Moghimi S
    Mol Immunol; 2008 Aug; 45(14):3797-803. PubMed ID: 18602161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.
    Roumenina LT; Daugan MV; Noé R; Petitprez F; Vano YA; Sanchez-Salas R; Becht E; Meilleroux J; Clec'h BL; Giraldo NA; Merle NS; Sun CM; Verkarre V; Validire P; Selves J; Lacroix L; Delfour O; Vandenberghe I; Thuilliez C; Keddani S; Sakhi IB; Barret E; Ferré P; Corvaïa N; Passioukov A; Chetaille E; Botto M; de Reynies A; Oudard SM; Mejean A; Cathelineau X; Sautès-Fridman C; Fridman WH
    Cancer Immunol Res; 2019 Jul; 7(7):1091-1105. PubMed ID: 31164356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune proteins C1q and mannan-binding lectin enhance clearance of atherogenic lipoproteins by human monocytes and macrophages.
    Fraser DA; Tenner AJ
    J Immunol; 2010 Oct; 185(7):3932-9. PubMed ID: 20833838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.